Oncolytika Ltd in Ely, CB6 3FL

Website

Zoom

www.oncolytika.com

Description

Data updated on: 01-11-2023

Oncolytika Ltd with the registration number 07305115 has been competing in the field for 14 years. The Private Limited Company is located at 1 The Firs, Wilburton in Ely and their area code is CB6 3FL. The firm's registered with SIC code 72110 meaning Research and experimental development on biotechnology. Oncolytika Limited released its latest accounts for the financial year up to 2022-07-31. The company's most recent confirmation statement was filed on 2023-06-23.

According to the latest data, there’s a single managing director in the company: Mark E. (since Tue, 6th Jul 2010). Since July 2010 Barbara K., had performed assigned duties for this specific business up to the moment of the resignation in July 2010.

Mark E. is the individual who controls this firm, has substantial control or influence over the company, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-07-31	2012-07-31	2013-07-31	2014-07-31	2015-07-31	2016-07-31	2017-07-31	2018-07-31	2019-07-31	2020-07-31	2021-07-31	2022-07-31	2023-07-31
Currency
Net Worth	37 198	31 566	43 330	43 560	48 387	53 541

Balance Sheet
Current Assets	58 650	30 985	49 140	67 477	70 503	80 051	88 228	104 348	163 449	140 024	205 311	131 003	88 861
Net Assets Liabilities						54 317	60 040	74 090	140 836	173 849	215 083	181 469	131 427
Cash Bank In Hand	42 573	6 486	31 271	17 528	36 684	27 499
Debtors	16 077	7 102	6 797	33 577	17 447	36 180
Net Assets Liabilities Including Pension Asset Liability	37 198	31 566	43 330	43 560	48 387	53 541
Stocks Inventory		6 325
Tangible Fixed Assets	4 134	21 178	16 699	12 170	12 022	3 885

Capital & Reserves
Called Up Share Capital	10	10	10	10	10	10
Profit Loss Account Reserve	37 188	31 556	43 320	43 550	48 377	53 531
Shareholder Funds	37 198	31 566	43 330	43 560	48 387	53 541

Other Financial Data
Accrued Liabilities Deferred Income						855	1 022	983	1 010	927	942	957	971
Average Number Employees During Period							2	1	2	2	2	2	2
Creditors						28 764	32 249	33 242	26 724	22 624	34 525	11 434	4 156
Fixed Assets	4 134	21 178	16 699	12 170	12 022	3 885	4 917	3 797	2 640	54 434	44 753	62 371	46 551
Net Current Assets Liabilities	33 891	14 624	29 971	33 824	38 769	50 433	56 145	71 276	139 206	120 342	171 272	120 055	85 847
Prepayments Accrued Income Not Expressed Within Current Asset Subtotal						279	166	170	2 481	2 942	486	486	1 142
Total Assets Less Current Liabilities	38 025	35 802	46 670	45 994	50 791	54 318	61 062	75 073	141 846	174 776	216 025	182 426	132 398
Creditors Due Within One Year	24 759	16 361	19 169	33 653	31 734	29 618
Current Asset Investments		11 072	11 072	16 372	16 372	16 372
Number Shares Allotted		10	10	10	10	10
Par Value Share		1	1	1	1	1
Provisions For Liabilities Charges	827	4 236	3 340	2 434	2 404	777
Share Capital Allotted Called Up Paid	10	10	10	10	10	10
Tangible Fixed Assets Additions		19 344	1 529	978	5 408	1 222
Tangible Fixed Assets Cost Or Valuation	5 045	24 389	25 918	26 896	32 304	15 661
Tangible Fixed Assets Depreciation	911	3 211	9 219	14 726	20 282	11 776
Tangible Fixed Assets Depreciation Charged In Period		2 300	6 008	5 507	5 556	3 859
Tangible Fixed Assets Depreciation Decrease Increase On Disposals						12 365
Tangible Fixed Assets Disposals						17 865

Company staff

Mark E.

Role: Director

Appointed: 06 July 2010

Latest update: 15 April 2024

People with significant control

Mark E.

Notified on 6 April 2016

Nature of control:

substantial control or influence

over 3/4 of shares

right to manage directors

Accounts Documents

Account next due date	30 April 2024
Account last made up date	31 July 2022
Confirmation statement next due date	07 July 2024
Confirmation statement last made up date	23 June 2023

Annual Accounts 4 April 2013
Start Date For Period Covered By Report	2011-08-01
End Date For Period Covered By Report	2012-07-31
Date Approval Accounts	4 April 2013
Annual Accounts
Start Date For Period Covered By Report	2012-08-01
End Date For Period Covered By Report	2013-07-31
Annual Accounts 24 April 2015
Start Date For Period Covered By Report	2013-08-01
End Date For Period Covered By Report	2014-07-31
Date Approval Accounts	24 April 2015
Annual Accounts 22 April 2016
Start Date For Period Covered By Report	01 August 2014
End Date For Period Covered By Report	31 July 2015
Date Approval Accounts	22 April 2016
Annual Accounts 15 April 2017
Start Date For Period Covered By Report	01 August 2015
End Date For Period Covered By Report	31 July 2016
Date Approval Accounts	15 April 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2016
End Date For Period Covered By Report	31 July 2017
Annual Accounts
Start Date For Period Covered By Report	01 August 2017
End Date For Period Covered By Report	31 July 2018
Annual Accounts
Start Date For Period Covered By Report	01 August 2018
End Date For Period Covered By Report	31 July 2019
Annual Accounts
Start Date For Period Covered By Report	01 August 2019
End Date For Period Covered By Report	31 July 2020
Annual Accounts
Start Date For Period Covered By Report	01 August 2020
End Date For Period Covered By Report	31 July 2021
Annual Accounts
Start Date For Period Covered By Report	01 August 2021
End Date For Period Covered By Report	31 July 2022
Annual Accounts
Start Date For Period Covered By Report	01 August 2022
End Date For Period Covered By Report	31 July 2023
Annual Accounts 25 April 2014
Date Approval Accounts	25 April 2014

Oncolytika Ltd

General information

Name:

Office Address:

Contact information

Website

www.oncolytika.com

Description

Financial data based on annual reports

Company staff

Mark E.

Barbara K.

People with significant control

Mark E.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies